Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation | Clinical Trial - ISAR-TRIPLE

Description:

The need for triple therapy with aspirin, clopidogrel, and a vitamin K antagonist is a commonly encountered clinical scenario in patients undergoing percutaneous coronary intervention (PCI), with concomitant conditions such as atrial fibrillation (AF) or venous thromboembolism (VTE). However, this appears to significantly increase the bleeding risk. The current trial sought to compare a 6-week versus a 6-month duration of triple therapy in patients undergoing drug-eluting stent (DES) implanta...